Name: Alto Neuroscience, Inc. (ANRO) Financial Statements
Creator: FinSpry

Alto Neuroscience Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Alto Neuroscience, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.21
Cost of Revenue	0.50	0.00	0.00	0.00
Gross Profit	-0.50	0.00	0.00	0.21
Operating Expenses
Research & Development	47.00	30.29	23.69	8.37
Selling, General & Administrative	21.61	7.52	5.50	3.90
Operating Expenses	68.11	37.81	29.19	9.29
Operating Income	-68.61	-37.81	-29.19	-9.08
Other Income/Expense
Interest Income	8.85	2.35	0.11	0.00
Interest Expense	-1.38	-1.37	0.00	0.00
Other Income/Expense	7.18	0.53	1.37	-0.11
Income
Income Before Tax	-61.43	-36.31	-27.71	-9.19
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-61.43	-36.31	-27.71	-9.19
Net Income - Continuous Operations	-61.43	-36.31	-27.71	-9.19
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-68.61	-37.44	-28.85	-8.94
EBIT	-61.43	-37.81	-29.19	-9.08
Depreciation & Amortization	-5.80	0.37	0.34	0.15
Earnings Per Share
Basic EPS	-2.00	-10.00	-8.00	-1.00
Diluted EPS	-2.00	-10.00	-8.00	-1.00
Basic Shares Outstanding	24.60	3.73	3.45	9.73
Diluted Shares Outstanding	24.60	3.73	3.45	9.73